Equity · Healthcare
VKTX
NASDAQViking Therapeutics (VKTX)
The line runs 32.94 USD on 13 August through 28.67 USD on 10 November, on a scale from 20 to 50. Days the market did not trade hold the previous close, flat.
- Market cap
- 3.7B USD
- Revenue, year to Dec 2025
- 0 USD
- EPS, diluted, year to Dec 2025
- −3.19 USD
- 52-week range
- 24.24 USD – 42.10 USD
- Avg volume
- 214.0K
- Mentions, 30 days
- 3
as of Nov 10, 2026
Have Viking Therapeutics (VKTX) insiders bought or sold shares recently?
VKTX's newest Form 4 filing is dated 1 August 2026: none in the last 90 days.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 29 Jul 2026 | Lian BrianPresident & CEO | Sell | 148,517 | 4.9M USD |
| 29 Jul 2026 | ZANTE GREGChief Financial Officer | Sell | 21,217 | 710K USD |
| 29 Jul 2026 | Mancini MariannaChief Operating Officer | Sell | 18,217 | 610K USD |
| 10 Mar 2026 | Aubuchon Neil WilliamChief Commercial Officer | Buy | 4,475 | 150K USD |
| 05 Jan 2026 | ZANTE GREGChief Financial Officer | Sell | 57,661 | 1.9M USD |
| 05 Jan 2026 | Mancini MariannaChief Operating Officer | Sell | 57,661 | 1.9M USD |
| 05 Jan 2026 | Lian BrianPresident & CEO | Sell | 233,409 | 7.7M USD |
| 02 Jan 2026 | FOEHR MATTHEW WDirector | Sell | 16,000 | 562K USD |
| 28 Oct 2025 | ZANTE GREGChief Financial Officer | Sell | 6,185 | 216K USD |
| 28 Oct 2025 | Lian BrianPresident & CEO | Sell | 38,989 | 1.4M USD |
| 28 Oct 2025 | Mancini MariannaChief Operating Officer | Sell | 6,185 | 216K USD |
| 27 Oct 2025 | Rowland Charles A Jr | Sell | 60,000 | 2.1M USD |
| Bought | 1 open-market purchase | 4,475 | $150K | |
| Sold | 11 open-market sales | 664,041 | $22.25M |
18 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 01 Aug 2026 | Kelly-Gemmell Dorothy ElizabethDirector | Award | 6,333 | |
| 28 Jul 2026 | Lian BrianPresident & CEO | Award | 221,667 | |
| 28 Jul 2026 | ZANTE GREGChief Financial Officer | Award | 31,667 | |
| 28 Jul 2026 | Mancini MariannaChief Operating Officer | Award | 31,667 | |
| 02 Jan 2026 | ZANTE GREGChief Financial Officer | Award | 73,049 | |
| 02 Jan 2026 | Mancini MariannaChief Operating Officer | Award | 73,049 | |
| 02 Jan 2026 | Lian BrianPresident & CEO | Award | 302,480 | |
| 02 Jan 2026 | SINGLETON J MATTHEWDirector | Award | 3,150 | |
| 02 Jan 2026 | MACARTNEY LAWSONDirector | Award | 3,150 | |
| 02 Jan 2026 | Rowland Charles A JrDirector | Award | 3,150 | |
| 02 Jan 2026 | FOEHR MATTHEW WDirector | Option exercise | 16,000 | 53K USD |
| 02 Jan 2026 | FOEHR MATTHEW WDirector | Award | 3,150 |
Showing the 12 most recent of 18 compensation filings in this window. The figures above count all of them.
Which funds hold Viking Therapeutics (VKTX)?
11 of the 45 institutional funds we track reported a Viking Therapeutics position for the quarter ended 30 Jun 2026 — a combined 328.6M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Two Sigma Investments | Held (±25%) | 3,937,414 | 153.6M USD | −11.2% |
| D. E. Shaw & Co. | Held (±25%) | 1,605,994 | 62.6M USD | −4.2% |
| Citadel Advisors | Held (±25%) | 951,515 | 37.1M USD | −24.6% |
| Millennium Management | Added | 498,172 | 19.4M USD | +98.9% |
| Point72 Asset Management | New position | 473,308 | 18.5M USD | |
| Man Group | Added | 312,171 | 12.2M USD | +30.5% |
| AQR Capital Management | Added | 200,958 | 7.8M USD | +1,551.0% |
| Tudor Investment Corp | Added | 197,331 | 7.7M USD | +178.8% |
| Balyasny Asset Management | Added | 115,906 | 4.5M USD | +217.6% |
| Bridgewater Associates | Held (±25%) | 87,859 | 3.4M USD | +23.3% |
Showing the 10 largest of 11 reported positions. The figures above count all of them.
What has been filed or recorded for Viking Therapeutics (VKTX)?
The filings we hold for Viking Therapeutics, newest first: 6 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 34,877 shares | 929K USD notional · 0.027% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,000 shares | 28K USD notional · 0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 4 shares | 114 USD notional · <0.001% of shares out |
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 5,684 shares | 185K USD notional · 0.004% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −1.55 USD | |
| 30 Sep 2026 | Financials | Total assets | 977.2M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 588.6M USD | at period end |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 16,812 shares | 555K USD notional · 0.013% of shares out |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 144,254 shares | 5.1M USD notional · 0.113% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −1.10 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −1.37 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −3.19 USD | |
| 31 Dec 2025 | Financials | Revenue | 0 USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −359.6M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −3.19 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.81 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.58 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.41 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −1.01 USD |
What is Reddit saying about Viking Therapeutics (VKTX)?
Reddit mentioned VKTX 3 times in the 30 days to 11 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 11 November 2026.
30-day window, Method
How do Reddit mentions of Viking Therapeutics (VKTX) compare with its price?
Share ↗
Which subreddits are talking about Viking Therapeutics (VKTX)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 3 | +0.12 |
What do people ask about Viking Therapeutics (VKTX)?
What did Viking Therapeutics shares close at?28.67
Viking Therapeutics closed at 28.67 USD on 10 Nov 2026, down 1.24% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Viking Therapeutics’ market cap?3.7B
Viking Therapeutics is worth 3.7B USD by market value as of 10 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Viking Therapeutics’ revenue?0
Viking Therapeutics reported revenue of 0 USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Viking Therapeutics insiders bought or sold shares recently?
No Viking Therapeutics insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 1 Aug 2026 (SEC Form 4). See Insiders
Which funds own Viking Therapeutics?11 of 45
11 of the 45 funds we track reported a Viking Therapeutics position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Two Sigma Investments, D. E. Shaw & Co. and Citadel Advisors. See Funds
When did Viking Therapeutics last report earnings?−1.55
Viking Therapeutics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −1.55 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Viking Therapeutics?0 mentions
Viking Therapeutics was mentioned 0 times in the last 7 days across the finance subreddits we track, and 3 times over the trailing 30 days. Of the 3 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings